Sutro Biopharma, Inc.
STRO
$7.30
-$0.72-8.95%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -56.86M | -11.50M | -75.97M | -72.44M | -48.79M |
| Total Depreciation and Amortization | 1.90M | 1.90M | 1.90M | 1.87M | 1.80M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.12M | 15.46M | 15.33M | 14.57M | -10.41M |
| Change in Net Operating Assets | 4.65M | -50.58M | -9.15M | -15.74M | -7.12M |
| Cash from Operations | -38.19M | -44.72M | -67.88M | -71.74M | -64.52M |
| Capital Expenditure | -251.00K | -86.00K | -1.17M | -1.07M | -828.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 40.24M | 2.67M | -15.08M | 88.56M | 148.12M |
| Cash from Investing | 39.99M | 2.58M | -16.26M | 87.49M | 147.29M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 127.00K | 0.00 | 246.00K | 0.00 | 1.09M |
| Repurchase of Common Stock | -25.00K | -60.00K | -180.00K | -24.00K | -74.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 102.00K | -60.00K | 66.00K | -24.00K | 1.02M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.90M | -42.20M | -84.08M | 15.73M | 83.79M |